Excellent. I have rich source material. Now let me deliver Module 2 in full.
🫁 MODULE 2: RESPIRATORY SYSTEM
Symptom-Based Approach
Quick spaced-repetition check from Module 1:
- The 6 Killers of chest pain: ACS, PE, Tension pneumothorax, Tamponade, disseCtion, Esophageal rupture (APT-TCE)
- Pericarditis ECG: diffuse ST elevation + PR depression (not regional, not reciprocal changes)
- Troponin timing: rises 3-6h, peaks 24h, normalizes 5-14 days
Now, the lungs.
SYMPTOM 3: COUGH
3.1 Definition and Classification
Cough is a forced expulsive maneuver, usually against a closed glottis, that generates high intrathoracic pressures (up to 300 mmHg) and expiratory airflow velocities approaching the speed of sound - designed to clear the airways.
It is classified by duration, which is your first and most powerful diagnostic tool:
| Duration | Category | Most Common Causes |
|---|
| <3 weeks | Acute | Viral URTI (most common), bacterial pneumonia, acute bronchitis, foreign body aspiration, pulmonary edema |
| 3-8 weeks | Subacute | Post-infectious/postviral, pertussis ("whooping cough"), resolving pneumonia |
| >8 weeks | Chronic | UACS, asthma, GERD, ACE inhibitor, chronic bronchitis, ILD, malignancy |
"Chronic cough is innocent until proven otherwise, but it demands explanation."
- Harrison's 22e: Chronic cough is one of the most common presenting complaints in outpatient medicine.
3.2 Pathophysiology of Cough
The cough reflex arc has four components:
RECEPTORS (afferent) → AFFERENT NERVE → COUGH CENTER → EFFERENT PATHWAY
Cough receptors: Located in larynx, carina (most sensitive),
bronchi, alveoli, pericardium, esophagus, stomach
(explains why GERD → cough without heartburn)
Afferent nerves: Vagus nerve (CN X) carries most signals
Some via trigeminal, phrenic, glossopharyngeal
Cough center: Brainstem (medulla) + voluntary cortical override
Efferent pathway: Recurrent laryngeal nerve (closes glottis) +
phrenic/intercostal nerves (generate expulsive force)
Pathological triggers:
- Mechanical: Secretions, foreign body, tumor compression
- Inflammatory: Cytokines lower the cough threshold (explains why post-viral cough persists weeks)
- Chemical: Acid (GERD), ACE inhibitor (bradykinin accumulation)
- Thermal: Cold air (exercise-induced asthma, cold-air testing)
- Neurogenic sensitization: Chronic cough hypersensitivity syndrome - central and peripheral sensitization without ongoing stimulus
3.3 The Three Most Common Causes of Chronic Cough
These account for >90% of chronic cough in non-smokers with a normal CXR - memorize this triad:
The "BIG THREE" of chronic cough (mnemonic: "GAP"):
GERD (gastroesophageal reflux disease)
Asthma (including cough-variant asthma)
Postnasal drip / Upper Airway Cough Syndrome (UACS)
Each can cause cough with no other classic symptoms (silent GERD, cough-variant asthma with no wheeze, UACS with minimal nasal symptoms).
Fourth cause never to miss: ACE inhibitor cough - affects 10-15% of patients, more common in women and Asian populations. Mechanism: ACE inhibitor prevents breakdown of bradykinin, which accumulates and stimulates cough receptors. Occurs within days to months of starting the drug. Resolves within 1-4 weeks of stopping.
Clinical Pearl from Harrison's 22e: "Any patient with chronic unexplained cough who is taking an ACE inhibitor should have a trial period off the medication, regardless of the temporal relationship between starting the medication and onset of the cough."
3.4 Complete Differential Diagnosis of Cough
ACUTE (<3 weeks):
- Viral URTI (rhinovirus, coronavirus, influenza) - most common cause of acute cough globally
- Acute bronchitis (usually viral; 95% do not need antibiotics)
- COVID-19 / influenza - fever, myalgia, dyspnea
- Pneumonia - fever, productive cough, consolidation
- Acute left ventricular failure - "cardiac cough," pink frothy sputum, nocturnal
- Foreign body aspiration - sudden onset, especially in children/elderly
- Inhalation injury - chemical, smoke
SUBACUTE (3-8 weeks):
- Post-infectious/postviral cough (most common) - residual airway inflammation
- Pertussis (Bordetella pertussis) - paroxysmal cough + inspiratory "whoop" + post-tussive vomiting; more common in adults than once thought
- Mycoplasma or Chlamydophila pneumonia - atypical, persistent, non-productive
CHRONIC (>8 weeks) - Systematic approach:
UACS / Postnasal Drip (30-40% of chronic cough):
- Rhinitis (allergic, vasomotor), sinusitis, adenoids
- Symptoms: sensation of drip down throat, throat clearing, nasal symptoms
- Exam: "cobblestoning" of posterior pharynx, mucus on posterior wall
Asthma / Cough-variant Asthma (20-25%):
- Classic asthma has wheeze + dyspnea + cough
- Cough-variant asthma: cough is the ONLY symptom - no wheeze, no dyspnea
- Diagnosis: methacholine challenge test (if negative, excludes asthma with high sensitivity)
- Key trigger: cold air, exercise, allergens, NSAIDs, beta-blockers
GERD (20%):
- Cough can occur without heartburn (extraesophageal manifestations)
- Mechanism: micro-aspiration of gastric contents + vagal reflex via esophageal acid stimulation
- Test: 24-hour pH monitoring (gold standard); empiric PPI trial often first
ACE inhibitor cough (10-15% of ACE inhibitor users):
- Switch to ARB (no bradykinin accumulation with ARBs)
Smoking / Chronic Bronchitis:
- Morning cough, productive, in a smoker >40 years old
- Definition of chronic bronchitis: productive cough >3 months/year for >2 consecutive years
- CXR may be normal; spirometry shows obstruction
ILD / Pulmonary Fibrosis:
- Dry, irritative cough + progressive dyspnea + bilateral "velcro" crackles at bases
- HRCT shows honeycombing (UIP pattern) or ground-glass opacities
Malignancy:
- Change in character of chronic cough in a smoker is lung cancer until proven otherwise
- Associated: hemoptysis, weight loss, clubbing, Horner syndrome (Pancoast)
Bronchiectasis:
- Chronic productive cough of large amounts of purulent sputum ("cupfuls")
- Three-layer sputum on standing (mucus on top, watery middle, purulent bottom)
- Associated: recurrent chest infections, clubbing
- Causes: post-TB, cystic fibrosis, primary ciliary dyskinesia, immunodeficiency
Non-asthmatic eosinophilic bronchitis (NAEB):
- Cough + sputum eosinophilia without bronchial hyperresponsiveness
- Responds to inhaled corticosteroids
Chronic Cough Hypersensitivity Syndrome:
- Increasingly recognized; central sensitization of cough reflex pathways
- No identifiable trigger; often triggered by talking, laughing, cold air
3.5 Red Flags in Cough - Must Not Miss
🚨
- Hemoptysis - always needs investigation (see Symptom 4 below)
- Weight loss + night sweats + chronic cough = TB or malignancy until proven otherwise
- Cough in a smoker >40 years old that changes character = lung cancer
- Stridor with cough = upper airway compromise
- Fever + productive cough + hypoxia = pneumonia - assess severity (CURB-65)
- New cough in immunocompromised patient = Pneumocystis jirovecii pneumonia (PJP), fungal, atypical
- Paroxysmal cough with post-tussive vomiting in adults = pertussis (underdiagnosed)
- Cough after a meal + recurrent chest infections = aspiration (neuromuscular disease, esophageal dysmotility)
3.6 Key History Questions for Cough
| Question | What It Tells You |
|---|
| How long? | Duration - acute/subacute/chronic framework |
| Productive or dry? | Productive = infection, bronchiectasis, CHF; Dry = viral, ACE-I, ILD, GERD, asthma |
| Color/character of sputum? | Yellow-green = infection; Pink/frothy = pulmonary edema; Rust-colored = pneumococcal pneumonia; "Currant jelly" = Klebsiella; Blood-streaked = varies (see hemoptysis) |
| When does it occur? | Nocturnal = asthma, GERD, post-nasal drip; Morning = chronic bronchitis/COPD; After meals = GERD/aspiration; With exercise = asthma |
| Triggers? | Cold air, allergens, exercise = asthma; Lying flat = GERD, CHF; Talking/laughing = hypersensitivity syndrome |
| Any ACE inhibitor / beta-blocker? | ACE-I = cough; beta-blocker = bronchospasm in asthmatic |
| Smoking history? | Pack-years; COPD, lung cancer risk |
| Occupation? | Farmer's lung (hypersensitivity pneumonitis), asbestosis, occupational asthma |
| Travel? | TB (endemic regions), histoplasmosis, melioidosis |
| Immunocompromised? | PJP, Cryptococcus, Aspergillus, NTM |
| Weight loss? Night sweats? | Malignancy, TB |
| Heartburn? Sour taste? | GERD |
| Nasal symptoms? | UACS/post-nasal drip |
3.7 Physical Examination for Cough
Always complete a full respiratory exam (as detailed in Module 1/Symptom 2).
Specific findings by diagnosis:
| Finding | Diagnosis Suggested |
|---|
| Cobblestoning of posterior pharynx | UACS/post-nasal drip |
| Wheeze (expiratory polyphonic) | Asthma, COPD |
| Fine "velcro" crackles at bases | ILD/pulmonary fibrosis |
| Coarse crackles + clubbing | Bronchiectasis |
| Monophonic wheeze (same pitch, same location) | Endobronchial lesion (tumor, foreign body) - refer for bronchoscopy |
| Dullness + absent breath sounds (base) | Pleural effusion |
| Lymphadenopathy + weight loss | Malignancy, TB, sarcoidosis |
| Digital clubbing | Bronchiectasis, ILD, lung cancer, cyanotic CHD (NOT asthma, NOT COPD) |
| Horner syndrome (ptosis, miosis, anhidrosis) | Pancoast tumor (apex of lung) |
| Superior vena cava obstruction (facial plethora, arm edema, distended veins) | Central lung cancer, lymphoma |
3.8 Algorithm for Chronic Cough
CHRONIC COUGH (>8 weeks)
|
v
CXR + Spirometry (FEV1/FVC, bronchodilator reversibility)
|
+---+---+
| |
ABNORMAL NORMAL
| |
Directed Smoking? On ACE-I?
workup |
(TB/cancer/ YES → Stop ACE-I / smoking cessation
ILD/COPD) NO
|
Treat for BIG THREE empirically:
1. Trial of nasal steroid + antihistamine (for UACS) x 2-4 weeks
2. Trial of high-dose PPI (for GERD) x 4-8 weeks
3. Spirometry + bronchodilator test / methacholine challenge (for asthma)
|
Still not resolved?
|
HRCT chest → Bronchoscopy → 24h pH monitoring
→ Consider NAEB (sputum eosinophils) → Chronic cough hypersensitivity
3.9 Investigations
| Test | Rationale |
|---|
| CXR | First test - consolidation, mass, effusion, mediastinal widening, hyperinflation |
| Spirometry | FEV1/FVC <0.7 = obstructive (COPD, asthma); if reversible (>12% and 200mL improvement after bronchodilator) = asthma |
| Methacholine challenge | Gold standard to diagnose asthma when spirometry is normal; a NEGATIVE test rules out asthma |
| Sputum culture + AFB | Pneumonia, TB |
| HRCT chest | ILD, bronchiectasis, early malignancy |
| Bronchoscopy | Suspected malignancy (direct visualization + biopsy), foreign body, hemoptysis localization |
| 24h pH monitoring / impedance | GERD as cause of cough (gold standard) |
| Full blood count | Eosinophilia (asthma, NAEB, eosinophilic pneumonia) |
| Pertussis PCR/serology | Subacute cough with paroxysms |
3.10 Mnemonics
Causes of chronic cough: "GASPED"
GERD, Asthma (cough-variant), Smoking/Bronchitis, Postnasal drip (UACS), Eosinophilic bronchitis, Drugs (ACE inhibitor)
Sputum colors: "PRGY CK" (read as: "Purge CK")
Pink frothy = pulmonary edema; Rust = pneumococcal; Green/yellow = infection; Yellow = purulent/eosinophilic; Currant jelly = Klebsiella; Kaolin/white = asthma/casts
Clubbing causes: "ABCDE"
Abscess (lung), Bronchiectasis, Carcinoma of lung, Diffuse ILD, Endocarditis (infective)
(Also: congenital cyanotic CHD, inflammatory bowel disease, cirrhosis)
SYMPTOM 4: HEMOPTYSIS
4.1 Definition and Classification
Hemoptysis = expectoration of blood originating from the lower respiratory tract (below the glottis).
First, confirm it is TRUE hemoptysis, not:
- Hematemesis (blood from GI tract - dark, coffee-ground, mixed with food, preceded by nausea, pH acidic, no bubbles)
- Pseudohemoptysis (blood from upper airway/nasopharynx, no respiratory symptoms)
Severity grading (Frameworks for IM, from textbook library):
| Grade | Volume | Clinical Significance |
|---|
| Submassive | <300 mL/24h | Most cases; usually not immediately life-threatening |
| Massive | >300-600 mL/24h (thresholds vary by source) | Life-threatening - death by ASPHYXIATION, not hemorrhage |
Key teaching point: In massive hemoptysis, the patient drowns in their own blood before exsanguinating. Airway control is the priority, not hemodynamic resuscitation.
4.2 Pathophysiology
The lungs have a dual blood supply:
- Pulmonary arteries (low pressure, ~25 mmHg systolic) - gas exchange
- Bronchial arteries (systemic pressure, ~120 mmHg) - airway nutrition
Most hemoptysis (>90%) comes from the bronchial circulation because it is high-pressure. This is why bronchial artery embolization (BAE) is the definitive intervention for massive hemoptysis.
Fishman's Pulmonary Diseases: "Inflammatory processes (bronchitis and bronchiectasis) and neoplasms are the most common causes of blood arising within the airways."
4.3 Complete Differential Diagnosis of Hemoptysis
Common causes (>80% of cases):
- Acute bronchitis / URTI (most common overall) - blood-streaked sputum, self-limited
- Pneumonia - rust-colored or blood-streaked; associated fever, consolidation
- Bronchiectasis - recurrent hemoptysis, copious sputum
- Tuberculosis - the classic cause; cavitating upper lobe disease; "Rasmussen's aneurysm" (mycotic aneurysm of pulmonary artery in a TB cavity - catastrophic)
- Lung cancer - streaking or frank hemoptysis; especially squamous cell carcinoma (central, cavitating)
- Lung abscess - foul-smelling sputum + hemoptysis + cavitation on CXR
Cardiovascular causes:
7. Pulmonary embolism with infarction - hemoptysis + pleuritic pain + dyspnea + risk factors
8. Mitral stenosis - mechanism: pulmonary venous hypertension + bronchial vein rupture (pulmonary apoplexy); "the hemoptysis of mitral stenosis is often sudden and large but typically self-limited" (Frameworks for IM)
9. Left ventricular failure - pink, frothy sputum = cardiogenic pulmonary edema
Immunological/vasculitic causes (rare but high-yield):
10. Goodpasture syndrome - anti-GBM antibodies causing pulmonary-renal syndrome: hemoptysis + hematuria + rapidly progressive glomerulonephritis
11. Granulomatosis with polyangiitis (GPA/Wegener's) - saddle nose deformity, sinusitis, hemoptysis, hematuria; c-ANCA positive
12. Microscopic polyangiitis - p-ANCA; pulmonary hemorrhage + renal disease
13. Systemic Lupus Erythematosus - lupus pneumonitis / alveolar hemorrhage
Infectious:
14. Fungal - Aspergillus (aspergilloma in old TB cavity - "fungus ball"), histoplasmosis, coccidioidomycosis
15. Paragonimiasis - parasitic lung fluke (travel to Asia/Africa); chronic cough + hemoptysis + eosinophilia
Other:
16. Coagulopathy - anticoagulant therapy, thrombocytopenia
17. AVM (arteriovenous malformation) - Osler-Weber-Rendu (hereditary hemorrhagic telangiectasia) - HHT; telangiectasias on lips/tongue, family history
18. Iatrogenic - post-bronchoscopy, post-biopsy, after bone marrow transplant (diffuse alveolar hemorrhage)
Age-based approach (Fishman's):
- <40 years: Infection (TB, bronchiectasis, lung abscess), mitral stenosis, AVM, vasculitis
- >40-45 years with smoking history: Lung cancer is the primary concern
4.4 Red Flags in Hemoptysis
🚨
- >300 mL in 24 hours = massive hemoptysis - emergency airway management
- Hemoptysis + weight loss + smoking history >40 yrs = malignancy until proven otherwise
- Hemoptysis + hematuria = pulmonary-renal syndrome (Goodpasture, GPA, SLE)
- Hemoptysis + cavitary upper lobe lesion = TB (especially in immigrant, HIV+, immunocompromised)
- New hemoptysis in a patient on anticoagulation - does NOT mean the anticoagulation is the cause; must find the underlying lesion
- Hemoptysis + telangiectasias + family history = HHT
- Hemoptysis + hemodynamic instability = bronchial artery embolization urgently
4.5 Immediate Management of Massive Hemoptysis
MASSIVE HEMOPTYSIS PROTOCOL:
1. AIRWAY: Intubate early (before total airway flooding)
→ Large bore ETT (≥8mm) to allow bronchoscopy
→ Position: bleeding lung DOWN (dependent) to protect the good lung
2. IV ACCESS: Two large-bore IVs + type and crossmatch
3. LOCALIZE: CXR, CT chest, bronchoscopy
→ Bronchoscopy: localizes bleeding AND can be therapeutic
(endobronchial tamponade, topical epinephrine, argon plasma coagulation)
4. DEFINITIVE:
→ Bronchial Artery Embolization (BAE) = first-line definitive therapy
(90%+ success rate for stopping bleeding)
→ Surgery (lobectomy) if BAE fails or technically impossible
→ In TB cavitary disease: consider cavernotomy
5. Treat underlying cause (antibiotics for TB/pneumonia/abscess)
4.6 Investigations for Hemoptysis
| Test | What it Reveals |
|---|
| CXR | Localizes only ~50% of cases (don't be fooled - a normal CXR does not rule out lung cancer) |
| CT chest (high-res) | Bronchiectasis, cavities, masses, AVMs; identifies bleeding source in ~77% |
| Bronchoscopy | Direct visualization; biopsy; therapeutic; gold standard for localization |
| FBC, coagulation screen | Thrombocytopenia, coagulopathy |
| Urinalysis + renal function | Pulmonary-renal syndrome (proteinuria, casts, elevated creatinine) |
| Anti-GBM antibodies | Goodpasture syndrome |
| ANCA (c-ANCA, p-ANCA) | GPA, microscopic polyangiitis |
| Sputum AFB smear + culture | TB |
| Sputum cytology | Malignant cells (sensitivity ~60%) |
| Bronchial angiography | Definitive pre-embolization mapping |
SYMPTOM 5: WHEEZE
5.1 Definition
Wheeze is a musical, continuous, high-pitched sound produced by turbulent airflow through narrowed airways. It is predominantly expiratory because airways narrow further on expiration (dynamic airway collapse).
Not all that wheezes is asthma - this is one of the most important clinical teaching points in respiratory medicine.
5.2 Complete Differential Diagnosis of Wheeze
| Category | Condition | Distinguishing Feature |
|---|
| Asthma | Bronchial asthma | Episodic, reversible, atopic history, responds to bronchodilators |
| COPD | Emphysema/chronic bronchitis | Smoker, fixed obstruction, barrel chest |
| Cardiac | Cardiac asthma (LVF) | Bilateral fine crackles + wheeze, elevated JVP, S3, responds to diuretics |
| Upper airway | Laryngeal/tracheal obstruction | Stridor (inspiratory), not true wheeze |
| Endobronchial | Tumor, foreign body | Monophonic wheeze, fixed, same pitch |
| Bronchiectasis | Post-TB, CF | Chronic productive cough + wheeze |
| Allergic reaction | Anaphylaxis | Urticaria, hypotension, throat tightness |
| ABPA | Allergic bronchopulmonary aspergillosis | Asthmatic + high IgE + central bronchiectasis |
| Vocal cord dysfunction | Paradoxical vocal fold motion | Inspiratory stridor, psychiatric comorbidity, spirometry: plateau on inspiratory limb |
5.3 The Great Imitators of Asthma
"Cardiac asthma" - LVF causing bronchospasm from peribronchial edema and vagal stimulation. Key differentiators:
- Older age, history of cardiac disease
- Elevated JVP, S3, bilateral fine crackles
- CXR: cardiomegaly + bilateral effusions + Kerley B lines
- BNP/NT-proBNP elevated
- Responds to IV furosemide + nitrates, NOT bronchodilators alone
Vocal Cord Dysfunction (VCD):
- Young women, often with psychological stress
- Inspiratory stridor, not expiratory wheeze
- Spirometry: flattening of the INSPIRATORY limb of flow-volume loop (vs. asthma: EXPIRATORY limb)
- Normal methacholine challenge
- Does NOT respond to bronchodilators; treated with speech therapy, breathing exercises
SYMPTOM 6: STRIDOR
6.1 Definition and Pathophysiology
Stridor is a high-pitched, monophonic, predominantly inspiratory sound caused by partial obstruction of the upper airway (larynx, trachea, subglottis).
Inspiratory stridor = above the larynx or at the glottis
Expiratory stridor = below the glottis / intrathoracic airways
Biphasic stridor = fixed obstruction at the glottis or subglottis
(Miller's Anesthesia: "A child with extrathoracic upper airway obstruction has inspiratory stridor, e.g., epiglottitis, laryngotracheobronchitis. A child with intrathoracic airway obstruction has expiratory stridor, e.g., bronchiolitis, asthma.")
6.2 Differential Diagnosis of Stridor by Age
Children (High-yield for NEET-PG/MRCP/USMLE Pediatrics):
| Condition | Age | Key Features |
|---|
| Croup (Laryngotracheobronchitis) | 6 months-3 years | Viral (parainfluenza); "barking seal" cough; "steeple sign" on AP neck X-ray; treat: nebulized epinephrine + dexamethasone |
| Epiglottitis | 2-7 years (now adults >children post-Hib vaccine) | H. influenzae type b (now Hib-vaccinated), sudden onset, HIGH fever, drooling, "tripod position," "thumbprint sign" on lateral neck XR; airway emergency |
| Foreign body aspiration | 6 months-4 years | Sudden onset in otherwise well child, right mainstem > left (more vertical angle) |
| Subglottic stenosis | Neonates, ex-intubated | Stridor from birth or post-extubation |
| Laryngomalacia | Neonates | Most common cause of congenital stridor; worsens when supine, improves prone; usually self-resolves |
Adults:
| Condition | Key Features |
|---|
| Anaphylaxis | Rapid onset, urticaria, hypotension - epinephrine IM immediately |
| Ludwig's angina | Bilateral submandibular space infection; floor of mouth elevation; dental source |
| Peritonsillar abscess | Unilateral tonsillar swelling, uvular deviation, "hot potato" voice |
| Retropharyngeal abscess | Neck stiffness, fever, posterior pharyngeal bulge |
| Angioedema | ACE inhibitor (bradykinin), hereditary (C1-esterase inhibitor deficiency) |
| Tracheal tumor / compression | Progressive; may have fixed monophonic wheeze |
| Post-extubation | Laryngeal edema, vocal cord palsy |
| Bilateral vocal cord palsy | Post-thyroidectomy (recurrent laryngeal nerve injury), post-intubation |
Epiglottitis EMERGENCY RULE: If epiglottitis is suspected, do NOT attempt to examine the throat with a tongue depressor or perform any invasive procedure until an anesthetist/ENT surgeon is present and the patient is in a fully equipped airway-management setting. The stimulus can cause complete airway obstruction.
THE BIG COMPARISON: ASTHMA vs. COPD vs. CARDIAC ASTHMA
This comparison is tested on every major exam. Internalize it:
| Feature | Asthma | COPD | Cardiac Asthma (LVF) |
|---|
| Age | Any (often <40) | Usually >40 | Usually >50-60 |
| Smoking | Not required | Almost always (>10 pack-years) | Not required |
| Onset | Episodic, reversible | Chronic, progressive | Acute/subacute, episodic |
| Nocturnal symptoms | Classic (3 AM) | Less prominent | PND at night |
| Sputum | White/clear, viscous | Chronic purulent (if bronchitis) | Pink frothy |
| Triggers | Allergens, cold, exercise, ASA/NSAIDs | Infections, air pollution | Fluid overload, arrhythmia, missed meds |
| Wheeze | Polyphonic expiratory | Polyphonic expiratory | Bilateral + crackles |
| JVP | Normal | May be raised (cor pulmonale) | Raised |
| CXR | Usually normal | Hyperinflation, flat diaphragm | Cardiomegaly, bat-wing opacities, Kerley B |
| Spirometry | Reversible obstruction (>12%+200mL) | Fixed obstruction (post-BD FEV1/FVC <0.7) | Normal (if treated) |
| BNP | Normal | Normal (unless cor pulmonale) | Very high |
| Response | Bronchodilators + ICS | Bronchodilators + ICS | Diuretics + nitrates |
| Clubbing | ABSENT | ABSENT | ABSENT |
Pearl: Clubbing is NEVER present in asthma or COPD alone. If you see a "COPD" patient with clubbing, search for lung cancer, bronchiectasis, or ILD as a complicating diagnosis.
PLEURAL EFFUSION: A Complete Approach
Light's Criteria (You MUST know this)
(Symptom to Diagnosis, 4th ed.)
An effusion is an exudate if ANY ONE of the following three criteria is met:
- Pleural fluid protein / Serum protein > 0.5
- Pleural fluid LDH / Serum LDH > 0.6
- Pleural fluid LDH > 2/3 upper limit of normal for serum LDH
Sensitivity 98%, Specificity 83%
If Light's criteria say "exudate" but you clinically suspect "transudate" (e.g., CHF with diuresis), use the Albumin gradient:
- Serum albumin - Pleural fluid albumin > 1.2 g/dL = TRANSUDATE (overrules Light's)
Transudates vs. Exudates
| Transudate | Exudate |
|---|
| CHF (most common) | Parapneumonic/Empyema |
| Cirrhosis (hepatic hydrothorax) | Malignancy |
| Nephrotic syndrome | TB |
| Hypothyroidism | Pulmonary embolism |
| Constrictive pericarditis | Rheumatoid arthritis / SLE |
| Meigs syndrome (ovarian fibroma) | Pancreatitis (left-sided) |
Additional pleural fluid analysis:
| Finding | Suggests |
|---|
| pH <7.2 | Empyema, malignancy, esophageal rupture |
| Glucose <60 mg/dL | Empyema, malignancy, rheumatoid (very low, ~0-10) |
| Lymphocyte >85% | TB or malignancy (PPV 97%) |
| Neutrophil >50% | Acute process: parapneumonic, PE |
| Triglycerides >110 mg/dL | Chylothorax (thoracic duct disruption - trauma, lymphoma) |
| Amylase elevated | Pancreatitis (left-sided), esophageal rupture |
| Mesothelial cells <5% | Highly suggestive of TB |
| Blood (haemothorax) | Trauma, malignancy, PE |
GOLD 2026 COPD CLASSIFICATION (Exam-Essential, Updated)
(GOLD 2026 Report - the latest as of July 2026)
Diagnosis: Post-bronchodilator FEV1/FVC <0.7 (fixed ratio criterion)
GOLD Severity Grades (based on FEV1 % predicted):
| Grade | Severity | FEV1 % Predicted |
|---|
| GOLD 1 | Mild | ≥80% |
| GOLD 2 | Moderate | 50-79% |
| GOLD 3 | Severe | 30-49% |
| GOLD 4 | Very severe | <30% |
ABE Groups (replaces old ABCD in GOLD 2023+):
| Group | Exacerbations | Symptoms |
|---|
| A | 0 or 1 (no hospitalization) | Low (mMRC 0-1 / CAT <10) |
| B | 0 or 1 (no hospitalization) | High (mMRC ≥2 / CAT ≥10) |
| E | ≥2 exacerbations OR ≥1 hospitalization | Any |
2026 update key point: Greater emphasis on early case-finding and pre-disease identification (GOLD Pre-COPD), and AI-assisted spirometry interpretation.
CLINICAL SCENARIO - RESPIRATORY MODULE
Patient: Mr. RK, 52-year-old ex-smoker (30 pack-years, stopped 2 years ago). Presents with 3-month history of progressively worsening dry cough. He denies fever, hemoptysis, or weight loss. He is on lisinopril for hypertension and is otherwise well. CXR is reported as "normal." Spirometry shows FEV1/FVC = 0.72, FEV1 = 88% predicted. Post-bronchodilator FEV1/FVC = 0.71 (not significant reversibility).
Your clinical reasoning:
- What is the most likely cause of his cough, and why is this the first thing you should address?
- His spirometry shows a mild fixed obstruction. How does this change your thinking?
- After stopping his lisinopril for 3 weeks, his cough persists. What do you do now?
- What test would confirm or exclude cough-variant asthma in this patient?
- At what point would you order a CT chest, and why?
(Attempt your answer before reading below)
Analysis:
- ACE inhibitor (lisinopril) cough is the first thing to address - it affects ~10-15% of users, is the most actionable cause, and simply requires switching to an ARB (e.g., losartan). Always do this FIRST before expensive investigations.
- The mild fixed obstruction on spirometry without significant reversibility is more consistent with early COPD (GOLD 1) or his smoking history than asthma. However, this does not explain the 3-month dry cough.
- Once ACE-I cough is excluded (cough persists >4 weeks after stopping), proceed through the BIG THREE: assess for UACS (nasal steroid trial), GERD (PPI trial), then asthma (methacholine challenge).
- Methacholine challenge test - if negative, excludes asthma with high sensitivity (~99% NPV). He would need normal spirometry for this - with FEV1 88%, he can safely undergo this.
- CT chest is ordered if: cough persists despite treating all three BIG THREE causes, any red flag emerges (hemoptysis, weight loss, change in sputum), or baseline CXR had any subtle abnormality. In a 52-year-old ex-smoker, low-dose CT chest is also part of lung cancer screening (per USPSTF criteria: 50-80 years, ≥20 pack-year history, current or quit within 15 years).
🧪 MODULE 2 SELF-ASSESSMENT QUESTIONS
Q6. A 65-year-old man coughs up about 400 mL of bright red blood over 4 hours. He is hypoxic (SaO2 86%), intubated in the ER, and is a known ex-smoker with old TB. CXR shows a right upper lobe cavity. What is the immediate positional maneuver you should perform after intubation, and what is the definitive intervention?
Q7. A 30-year-old woman presents with wheeze and breathlessness that is worse in the morning and improves through the day. She reports her symptoms worsen around cats. Spirometry shows FEV1/FVC = 0.62, FEV1 = 71%, with 18% improvement (320 mL) after salbutamol. What is the diagnosis, and what is the spirometric definition of significant reversibility?
Q8. A 45-year-old female patient on ramipril 5mg for hypertension developed a dry tickling cough 8 months ago. Her CXR and spirometry are normal. You stop ramipril and start losartan. How long do you wait to reassess, and what do you tell the patient?
Q9. A patient has a left-sided pleural effusion. Thoracentesis reveals: protein 45 g/L (serum 68 g/L), LDH 310 U/L (serum 420 U/L), pH 6.9, glucose 12 mg/dL. What is the most likely diagnosis, and what does the very low pH suggest?
Q10. Describe the "steeple sign" and the "thumbprint sign" - what does each indicate, and how does the immediate management differ?
📌 SPACED REPETITION REMINDERS FOR NEXT SESSION
In Module 3 (Gastrointestinal), I will test you on:
- The 6 Killers of chest pain (from Module 1) without prompting
- Light's criteria thresholds (from this module) from memory
- The three most common causes of chronic cough
SOURCES USED - MODULE 2
- Harrison's Principles of Internal Medicine, 22nd Edition (2025) - Chapters on Cough (Ch. 40) and Dyspnea (Ch. 39)
- Frameworks for Internal Medicine - Hemoptysis key points and mitral stenosis hemoptysis mechanism
- Fishman's Pulmonary Diseases and Disorders - Hemoptysis causes (Table 27-10), pathophysiology
- Symptom to Diagnosis: An Evidence-Based Guide, 4th Edition - Light's criteria with sensitivity/specificity data
- ROSEN's Emergency Medicine - Stridor, upper airway obstruction, epiglottitis
- GOLD 2026 COPD Report - Current classification and diagnostic criteria
- Miller's Anesthesia - Pediatric airway obstruction and stridor
Module 2 complete. When you're ready, type "Continue to Module 3" for the Gastrointestinal System, covering:
- Abdominal pain (the most complex symptom in medicine)
- Nausea and vomiting
- Diarrhea (acute and chronic)
- Constipation
- Gastrointestinal bleeding (upper and lower)
- Including the complete approach to the acute abdomen, peritonitis, and obstruction
Before continuing, try at least Questions 6 and 9 above - they are classic MRCP/USMLE Part 2 clinical vignettes that test exactly the concepts from this module.